Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $499,000 direct costs per year, for a maximum project period of 5 years (R01 mechanism).

Summary: Supports projects to expand, improve, or transform the use of mammalian cancer and tumor models for translational research, with the goal of enhancing their clinical relevance and impact.

Key Information: Clinical trials are not allowed; foreign and domestic organizations are eligible; Data Management and Sharing Plan required.